They are all expired
Inventor
David Shonfeld
They are all expired
Inventor
David Shonfeld
Joel S. Schoenfeld
Current Assignee
Univec Inc
Worldwide applications
1994 US 1995 BR CN KR AU EP WO CA RU 1996 BR EP CA AU US WO
Application US08/232,749 events
1994-02-14
Priority to US08/195,302
1994-04-25
Application filed by Univec Inc
1996-10-08
Application granted
1996-10-08
Publication of US5562623A
2014-02-14
Anticipated expiration
Status
Expired - Lifetime
Inventor
David Shonfeld
Current Assignee
Univec Inc
Worldwide applications
1993 US
Application US08/151,812 events
1992-12-28
Priority to US99731392A
1993-11-15
Application filed by Univec Inc
1994-12-06
Application granted
1994-12-06
Publication of US5370620A
2012-12-28
Anticipated expiration
Status
Expired - Fee Related
Inventor
David Shonfeld
Joel S. Schoenfeld
Current Assignee
Univec Inc
Worldwide applications
1994 US
Application US08/195,302 events
1994-02-14
Application filed by Univec Inc
1994-02-14
Priority to US08/195,302
1996-07-02
Application granted
1996-07-02
Publication of US5531691A
2014-02-14
Anticipated expiration
Status
Expired - Fee Related
Inventor
David Shonfeld
Joel Schoenfeld
Current Assignee
Univec Inc
Worldwide applications
1997 US
Application US08/782,040 events
1997-01-10
Application filed by Univec Inc
1997-01-10
Priority to US08/782,040
1997-03-17
Assigned to UNIVEC INC.
1999-04-06
Application granted
1999-04-06
Publication of US5891104A
2000-04-10
Assigned to BUSINESS ALLIANCE CAPITAL CORP.
2017-01-10
Anticipated expiration
Status
Expired - Fee Related
Inventor
David Shonfeld
Joel Schoenfeld
Current Assignee
Univec Inc
Worldwide applications
1997 US
Application US08/782,040 events
1997-01-10
Application filed by Univec Inc
1997-01-10
Priority to US08/782,040
1997-03-17
Assigned to UNIVEC INC.
1999-04-06
Application granted
1999-04-06
Publication of US5891104A
2000-04-10
Assigned to BUSINESS ALLIANCE CAPITAL CORP.
2017-01-10
Anticipated expiration
Status
Expired - Fee Related
Inventor
Joel Schoenfeld
Randy Cohen
Current Assignee
Univec Inc
Worldwide applications
2001 US
Application US09/781,747 events
2000-02-10
Priority to US18159200P
2001-02-12
Application filed by Univec Inc
2001-02-12
Priority to US09/781,747
2001-12-06
Publication of US20010049506A1
2003-03-18
Application granted
2003-03-18
Publication of US6533756B2
2021-02-18
Adjusted expiration
Status
Expired - Fee Related
1
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Class Action Against Newmont Corporation In recent news, investors in Newmont Corporation (NEM) are urged to take notice of a class action securities lawsuit activated by Levi & Korsinsky, LLP. This legal endeavor aims to seek restitution for shareholders impacted by alleged fraudulent activities linked to the company’s operations. What is the Class...
Continue Reading
Quarterly Distributions Announced by Plains All American Plains All American Pipeline, L.P. (NASDAQ: PAA) and Plains GP Holdings (NASDAQ: PAGP) have just shared their quarterly distributions for the third quarter of 2024, making this an important update for shareholders and investors alike. Details of the Quarterly Distribution The companies revealed a consistent approach...
Continue Reading
FLSmidth 2024 Annual Report Highlights Major Achievements On February 20, 2025, FLSmidth’s Board of Directors approved the Annual Report for 2024, showcasing significant improvements in profitability and outlining the progress made towards key transformation efforts. Major Highlights from 2024 include: Increased Mining Service order intake by 2% from the previous year,...
Continue Reading
Exploring the Mixed Signals in the German Stock Market The German stock market concluded on a mixed note recently, reflecting a variety of performance trends among different sectors. While certain sectors saw positive movement, others faced declines, illustrating the complexity of the current economic environment. DAX Performance and Sector Shifts At the closing bell in...
Continue Reading
Understanding Ray Dalio's Economic Perspective In a recent discussion, renowned investor Ray Dalio analyzed the shifting economic landscape under the upcoming presidential administration. He highlighted the potential changes that could significantly affect how tech companies operate in a less regulated environment. Potential Changes in the Regulatory Landscape Dalio's...
Continue Reading